@FierceMedDev: Popular this week: Inventor launches crowdfunding hub for medical devices. Article | Follow @FierceMedDev
@DamianFierce: Finally, some good news for Navidea: Medicare expansion and a Siemens partnership. Report | Follow @DamianFierce
@MarkHFierce: In 2012, medical device employment at the top companies mostly grew, due to M&A and organic growth. ICYM the feature | Follow @MarkHFierce
> Abbott Laboratories ($ABT) has wrapped up its $310 million deal for IDEV Technologies. Release
> Canadian diagnostics outfit GeneNews ($GEN) plans to cut 60% of its staff by Nov. 30. Item
> San Diego's Tensys Medical won Chinese approval for its TL-300 patient monitoring system, and it plans to launch the device immediately through a local partner. News
> Reverse Medical snagged FDA clearance for its MVP vascular plug designed for peripheral artery embolization. More
> Exosome Diagnostics has teamed up with the Icahn School of Medicine at Mount Sinai to develop in vitro tests for cancer, inflammatory diseases and other ailments. More
> Arizona startup HealthTell raised $4 million to develop diagnostic tests for lung, breast, prostate and colorectal cancers. Report
> Taiwan's Apex Medical is fighting back against ResMed's patent challenge over sleep apnea devices. Story
Biotech News
@FierceBiotech: Popular yesterday: Novartis wins a record breakthrough therapy designation for orphan drug. Article | Follow @FierceBiotech
@JohnCFierce: Just came across my story on first IPO of '13 - $STML, priced at $10, now $34.55. Hopeful signs, indeed. Article | Follow @JohnCFierce
@EmilyMFierce: This week's issue of FierceBiotechResearch. Report | Follow @EmilyMFierce
> Basilea shares dented after FDA digs in on antibiotic PhIII rule. Story
> Trial co-op persuades pharmas to stop sabotaging head-to-head drug studies. More
> Incyte shares surge on positive pancreatic cancer trial data for Jakafi. News
Pharma News
@FiercePharma: Novartis picks Dublin site for new regional business center, on track for 100 new jobs there. More | Follow @FiercePharma
@EricPFierce: Alexion recalls some Soliris in EC "due to the presence of visible particles in a limited number of vials." More from FiercePharmaManufacturing | Follow @EricPFierce
@CarlyHFierce: Shire enlists help fighting unwanted takeover. Another co. seeking access to Ireland's tax regime? Popular yesterday from FiercePharma | Follow @CarlyHFierce
> China's pharma probe intensifies with British consultant's arrest. More
> India's Biocon promises Herceptin biosim launch by fiscal year-end. Article
> Allergan pushes FDA to defend Restasis from early generics. Report
Biomarkers News
> Blood samples may aid suicide risk prediction. Story
> Possible psychosis biomarker found in brain "folding." Story
> Potential Alzheimer's biomarker targeted in brain fluid. More
> Lung cancer gene variants could help boost survival odds. Article
> Biomarker gauges graft-versus-host disease risk for stem cell transplant patients. Item
Drug Delivery News
@MichaelGFierce: Time-release delivery of vision-loss drug demands fewer injections. More | Follow @MichaelGFierce
> Study: Insulin pumps improve glycemic control in children with diabetes. Story
> Bind launches second PhII trial for prostate cancer nanomed. More
> Alnylam wins two orphan designations for hemophilia RNAi drug. Report
> Platinum-based radiotherapy method zaps cancer with nanomeds. Article